Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.40%
#2 Pons Pons +35.27%
#3 Purr Purr +33.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.57%
#5 TENDIES TENDIES +28.48%
#6 Starpower Starpower +28.34%
#7 StonkBroker StonkBroker +23.34%
#8 SkyAI SkyAI +23.33%
#9 PondCoin PondCoin +22.89%
#10 Magma Finance Magma Finance +22.43%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Clasificación en acciones #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Precio por acción
$152.40
Capitalización bursátil
$376.40B
Cambio (1 día)
12.48%
Cambio (1 año)
79.44%
País
US
Comercio Merck & Co., Inc. (MRK)

Categoría

Healthcare
Ratio P/S de Merck & Co., Inc. (MRK)
Ratio P/S al August 2026 TTM: 5.05
Según los informes financieros más recientes y el precio de las acciones de Merck & Co., Inc., el ratio P/S actual (TTM) es 5.05. Al final de 2024, el ratio P/S era 3.93.
Historial del ratio P/S de Merck & Co., Inc. desde 2000 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 5.05 24.45%
2025 4.06 3.42%
2024 3.93 -16.98%
2023 4.73 -0.22%
2022 4.74 19.03%
2021 3.98 -16.24%
2020 4.75 -16.41%
2019 5.69 27.31%
2018 4.47 23.86%
2017 3.61 -6.97%
2016 3.88 9.28%
2015 3.55 -2.53%
2014 3.64 14.68%
2013 3.17 26.92%
2012 2.50 9.87%
2011 2.28 -1.64%
2010 2.31 -13.63%
2009 2.68 3.16%
2008 2.60 -47.76%
2007 4.97 24.28%
2006 4.00 32.11%
2005 3.03 2.25%
2004 2.96 -32.43%
2003 4.38 -22.89%
2002 5.68 -6.12%
2001 6.05 18.63%
2000 5.10 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.95 176.11%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.41 26.80%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.85 35.47%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -7.81%
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 9.26%
CH